Location: Exton, PA
President and CEO
Absorption Systems LP was founded to address an issue that has plagued drug discovery research since its inception: Can we predict from laboratory experiments in cells or tissue samples what will happen when that same molecule is dosed in humans? In-vitro tools and approaches to better predict human outcomes, or explain unanticipated outcomes, are part of an emerging branch of science termed “translational medicine.” “One example of translational medicine in which Absorption Systems is a world leader is the use of human intestinal-derived cells to predict the extent of drug absorption in humans,” says president and CEO Patrick Dentinger.
WORDS OF WISDOM: “Energy and persistence conquer all things.” – Benjamin Franklin
In its 20 years in the Greater Philadelphia area, Absorption Systems has helped more than 60 pharmaceutical companies from around the world eliminate unnecessary human testing and gain regulatory approval in the U.S. While the company’s clientele spans the globe, its expertise is centered in Exton. “Today, our company employs more than 120 employees, 80 of which reside in the Greater Philadelphia region,” says Dentinger.